053-Precision Immunotherapy for Early-Stage NSCLC

This paper outlines the revolutionary impact of immunotherapy on early-stage non-small cell lung cancer (NSCLC), acknowledging its significant benefits while highlighting the inconsistency of current biomarker predictions. It emphasizes the importance of integrated multiomic approaches, combining tumor characteristics, immune microenvironment, and systemic factors, to enhance patient stratificatio...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动